|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007138,
umls-concept:C0017262,
umls-concept:C0185117,
umls-concept:C0220901,
umls-concept:C0597298,
umls-concept:C1332712,
umls-concept:C1335749,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C1709900,
umls-concept:C2911684
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-3-11
|
|
pubmed:abstractText |
We retrospectively evaluated the expression and prognostic value of CD44 isoforms in transitional cell carcinoma of the renal pelvis and ureter.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
161
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
805-8; discussion 808-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10022688-Adult,
pubmed-meshheading:10022688-Aged,
pubmed-meshheading:10022688-Aged, 80 and over,
pubmed-meshheading:10022688-Antigens, CD44,
pubmed-meshheading:10022688-Carcinoma, Renal Cell,
pubmed-meshheading:10022688-Female,
pubmed-meshheading:10022688-Humans,
pubmed-meshheading:10022688-Immunohistochemistry,
pubmed-meshheading:10022688-Kidney Neoplasms,
pubmed-meshheading:10022688-Kidney Pelvis,
pubmed-meshheading:10022688-Male,
pubmed-meshheading:10022688-Middle Aged,
pubmed-meshheading:10022688-Prognosis,
pubmed-meshheading:10022688-Protein Isoforms,
pubmed-meshheading:10022688-Retrospective Studies,
pubmed-meshheading:10022688-Tumor Markers, Biological,
pubmed-meshheading:10022688-Ureteral Neoplasms
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
|
|
pubmed:affiliation |
Department of Urology, Yokohama City University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article
|
